0102030405
Apremilast CAS No. 608141-41-9 Pharmaceutical Intermediates
02
Overview of Apremilast
Apremilast is a groundbreaking therapeutic agent that has revolutionized the management of chronic inflammatory diseases. It is particularly effective for patients suffering from moderate to severe plaque psoriasis and active psoriatic arthritis. By targeting the underlying mechanisms of inflammation, Apremilast offers a unique approach to treatment, providing significant relief for patients who may not respond to traditional therapies.
02
product detail
|
CAS No. |
40856-44-8 |
|
EINECS |
609-874-3 |
|
Formula |
C9H11NO2 |
|
Molecular Weight |
165.19 |
|
Appearance |
White to Off-White solid |
|
Purity |
≥98% |
|
Type |
Pharmaceutical Intermediates |
Apremilast is characterized by its unique physical and chemical properties, which contribute to its efficacy and stability. The compound appears as a white to off-white crystalline powder, with a molecular formula of C22H24N2O5S and a molecular weight of 420.50 g/mol. It is highly soluble in organic solvents such as dimethyl sulfoxide (DMSO) and methanol, making it suitable for various formulations and applications in laboratory settings.
The stability of Apremilast under different environmental conditions is a significant advantage, allowing for an extended shelf life and reliable performance in both clinical and research applications. Its low toxicity profile further enhances its appeal as a therapeutic agent, making it a preferred choice for healthcare providers and researchers alike.
1. Targeted Mechanism of Action: Apremilast specifically inhibits the PDE4 enzyme, which plays a crucial role in the inflammatory process. This targeted action helps to reduce the production of pro-inflammatory cytokines, leading to improved patient outcomes.
2. Convenient Oral Administration: Unlike many biologic therapies that require injections, Apremilast is administered orally, providing a convenient and patient-friendly option for long-term management of chronic conditions.
3. Favorable Safety Profile: Clinical studies have shown that Apremilast has a favorable safety profile, with fewer side effects compared to traditional systemic therapies. This makes it an attractive option for patients who may be sensitive to other medications.
4. Comprehensive Laboratory Support: Our company not only provides Apremilast but also offers a range of laboratory instruments and consumables that support its use in research and clinical applications. This ensures that our clients have access to the tools they need for accurate and effective results.
5. Global Reach and Compliance: As a foreign trade company, we are committed to delivering high-quality products to clients around the world. Our expertise in international logistics ensures that Apremilast is available to healthcare providers and researchers in various regions, complying with all necessary regulatory standards.
In summary, Apremilast is a revolutionary treatment option for chronic inflammatory conditions, offering a unique mechanism of action, favorable physical and chemical properties, and a range of advantages that set it apart from traditional therapies. Supported by our extensive experience in foreign trade and commitment to quality, we are proud to provide Apremilast as a reliable solution for healthcare professionals and researchers alike. Choose Apremilast for effective, targeted therapy that meets the needs of your patients and enhances your research capabilities.
By investing in Apremilast, you are not only choosing a high-quality therapeutic agent but also partnering with a company dedicated to excellence in global trade and customer satisfaction. Experience the difference with Apremilast today!